HUMA - Humacyte extends gains as FDA reviews blood vessel product
2024-05-14 07:28:38 ET
More on Humacyte
- Humacyte, Inc. (HUMA) Q1 2024 Earnings Call Transcript
- Humacyte, Inc. (HUMA) Q4 2023 Earnings Call Transcript
- Humacyte GAAP EPS of -$0.24 in-line
- Humacyte stock dips after pricing stock offering to raise $40.2M
- Seeking Alpha’s Quant Rating on Humacyte